Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

The Dow and S&P 500 faced a slight dip. However, Nasdaq managed a record high close. Eli Lilly shares fell due to ...

Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a ...

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

Kelly Clarkson's Ex-Husband Brandon Blackstock Dead At 48 What You're Really Eating When You Order Taco Bell Helicopter ...

Key Takeaways The S&P 500 slid 0.1% on Thursday, Aug. 7, 2025, as new tariffs took effect, raising import duties on goods from numerous U.S. trading partners.Shares of pharmaceutical giant Eli Lilly ...

Major Wall Street indexes were mixed on Thursday, with the Dow and S&P 500 ending lower, as European stocks closed at a one-week high on strong financial stocks and hopes of a Ukraine ceasefire. U.S.

The data hasn't been peer-reviewed yet but the drug company said their average patient lost 27 pounds in over 72 weeks.

Drug giant Eli Lilly plunged more than 6% after the company's weight-loss drug trial data disappointed investors. Meanwhile, Eli Lilly reported strong second-quarter earnings and sales results, ...

Thursday closed down -0.08%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.51%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.32%. September E-mini S&P futures (ESU25) fell -0.04% ...

Eli Lilly & Co. tumbled as disappointing data on its new weight-loss pill overshadowed strong growth from the company’s current obesity medicine, which helped drive it to raise its yearly profit and ...

The main indexes finished well off their session highs after a disappointing batch of corporate earnings reports.